A Brief Mind-Body Bridging Intervention for Suicidal Ideation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03677882|
Recruitment Status : Recruiting
First Posted : September 19, 2018
Last Update Posted : April 26, 2019
|Condition or disease||Intervention/treatment||Phase|
|Suicidal Ideation Mind Body Bridging||Behavioral: Mind Body Bridging Group Session||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||70 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Randomized Pilot Study of a Brief Mind-Body Bridging Intervention for Suicidal Ideation|
|Actual Study Start Date :||December 18, 2018|
|Estimated Primary Completion Date :||October 31, 2020|
|Estimated Study Completion Date :||October 31, 2022|
No Intervention: Treatment as Usual (TAU)
Participants assigned to Treatment As Usual (TAU) will receive the normal standard of care treatment from the Suicide Prevention Team and the Mental Health Service which may include individual therapy, group therapy, and/or medication therapy, all as decided by the individual and his/her doctor. Treatment as usual also includes monitoring by the Suicide Prevention Team.
Experimental: Treatment As Usual with Mind-Body Bridging (TAU + MBB)
Participants assigned to TAU + MBB will will receive treatment from the Suicide Prevention Team and the Mental Health Service, AND will be asked to participate in four, 90-minute Mind Body Bridging group sessions that will occur for four weeks in a row. Each group will involve up to 15 participants and will be led by a trained MBB facilitator.
Behavioral: Mind Body Bridging Group Session
Participants assigned to TAU + MBB will will receive treatment from the Suicide Prevention Team and the Mental Health Service, AND will be asked to participate in four, 90-minute Mind Body Bridging group sessions that will occur for four weeks in a row. Each group will involve up to 15 participants and will be led by a trained MBB facilitator. Participants will receive a workbook at the beginning of the training that contains an explanation of all the major concepts involved in Mind Body Bridging. The workbook has homework assignments to be completed daily between group sessions.
- Change in frequency and/or intensity of suicidal ideation [ Time Frame: Weekly during the intervention, one-month post-intervention, three months post-intervention, six months post-intervention ]Determine if there is a significant difference in the frequency and/or intensity of suicidal ideation, as measured by the Beck Scale for Suicide Ideation (BSS) among the MBB-SI + TAU cohort compared to the TAU. We will use the total BSS score, ranging from 0 to 38. Increased scores reflect greater suicide risk.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03677882
|Contact: Don Glover, PhD||8015821565 ext email@example.com|
|Contact: Jessica Vasa, LCSWfirstname.lastname@example.org|
|United States, Utah|
|George E. Wahlen Department of Veterans Affairs Medical Center||Recruiting|
|Salt Lake City, Utah, United States, 84148|
|Contact: Don Glover, PhD 801-558-1565 ext 2325 email@example.com|
|Principal Investigator:||Don Glover, PhD||VA Salt Lake City HCS|